Myeloid differentiation (MyD) primary response genes in hematopoiesis

Blood Cells, Molecules, and Diseases

Volumn 31, Issue 2, 2003, Pages 213-228

  Liebermann, Dan A ^a   Hoffman, Barbara ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; EGR 1; Gadd34; GADD45; Hematopoiesis; IRF 1; Jun; MyD116; MyD118; MyD88

Indexed keywords

CELL CYCLE PROTEIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 1; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR;

APOPTOSIS; CELL DIFFERENTIATION; CELL LINEAGE; GENE; GENE FUNCTION; GROWTH INHIBITION; HEMATOPOIESIS; HOMEOSTASIS; HUMAN; IMMUNITY; INFLAMMATION; MYELOID DIFFERENTIATION PRIMARY RESPONSE GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STRESS; BLOOD CELL; BONE MARROW CELL; CELL GROWTH; CELL MATURATION; CELL SPECIFICITY; DNA DAMAGE; GENETIC ANALYSIS; MOLECULAR CLONING;

EID: 0043238927     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-9796(03)00160-8     Document Type: Article

References (212)

1. Lord K.A., Hoffman-Liebermann B., Liebermann D.A. Complexity of the immediate early response of myeloid cells to terminal differentiation and growth arrest includes ICAM-1, Jun-B and histone variants. Oncogene. 5:1990;387-396.
2. Abdollahi A., Lord K.A., Hoffman-Liebermann B., Liebermann D.A. Interferon regulatory factor-1 is a myeloid differentiation primary response gene induced by IL6 and leukemia inhibitory factor role in growth inhibition . Cell Growth Diff. 2:1991;401-407.
3. Lord K.A., Abdollahi A., Hoffman-Liebermann B., Liebermann D.A. Dissection of the immediate early response of myeloid leukemia cells to terminal differentiation and growth inhibitory stimuli. Cell Growth Diff. 1:1990;637-645.
4. Nguyen H., Hoffman-Liebermann B., Liebermann D.A. The zinc finger transcription factor EGR-1 is essential for and restricts differentiation along the macrophage lineage. Cell. 72:1993;197-209.
5. Abdollahi A., Lord K.A., Hoffman-Liebermann B., Liebermann D.A. Sequence and expression of a cDNA encoding MyD118 a novel myeloid differentiation primary response gene induced by multiple cytokines . Oncogene. 6:1991;165-167.
6. Lord K.A., Hoffman-Liebermann B., Liebermann D.A. Sequence of MyD116 cDNA a novel myeloid differentiation primary response gene induced by IL6 . Nucleic Acids Res. 18:1990;2823.
7. Lord K.A., Hoffman-Liebermann B., Liebermann D. Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6. Oncogene. 5:1990;1095-1097.
8. Fujita T., Kimura Y., Miyamoto M., Barsoumian E.L., Taniguchi T. Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor IRF-1. Nature. 337:1989;270-272.
9. Harada H., Willison K., Sakakibara J., Miyamoto M., Fujita T., Taniguchi T. Absence of the type 1 IFN system in EC cells transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated . Cell. 63:1990;303-312.
10. Miyamoto M., Fugita T., Kimura Y., Maruyama M., Harada H., Sudo Y., Miyata T., Taniguchi D. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell. 54:1988;903-913.
11. Squier M.K., Sehnert A.J., Cohen J.J. Apoptosis in leukocytes. J. Leukoc. Biol. 57:1995;2-10.
12. Matsuyama T., Kimura T., Kitagawa M., Pfeffer K., Kawakami T., Watanabe N., Kundig T.M., Amakawa R., Kishihara K., Wakeham A., Potter J., Furlonger C.L., Narendran A., Suzuki H., Ohashi P.S., Paige C.J., Taniguchi T., Mak T.W. Target ed disruption of IRF-1 or IRF-2 results in abnormal type 1 IFN gene induction and aberrant lymphocyte development. Cell. 75:1993;83-97.
13. Willman C.L., Sever C.E., Palavicini M.G., Harada H., Tanaka N., Slovak M.L., Yamamoto H., Harada K., Meeker T.C., List A.F., Taniguchi T. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science. 259:1993;968-971.
14. Harada H., Kondo T., Ogawa S., Tamura T., Kitagawa M., Tanaka N., Lamphier M.S., Hirai H., Taniguchi T. Accel-eratedexon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; apossible mechanism of tumor sup-pressorinactivation. Oncogene. 9:1994;3313-3320.
15. Mayeda A., Helfman D.M., Krainer A.R. Modulation of exon skipping and inclusion by heterogeneous nuclearribonucleoprotein A1 and pre-mRNAsplicing factor SF2/ASF. Mol. Cell. Biol. 13:1993;2993-3001.
16. Taniguchi T., Ogasawara K., Takaoka A., Tanaka N. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:2001;623-655.
17. Janeway C.A., Travers P., Walport M., Capra D. The Immune System in Health and Disease. 4th Ed. 1999;Garland, New York.
18. Nakanishi K. Innate and acquired activation pathways in T cells. Nat. Immunol. 2:2001;140-142.
19. Taki S., Sato T., Ogasawara K., Fukuda T., Sato M., Hida S., Suzuki G., Mitsuyama M., Shin E.H., Kojima S., Taniguchi T., Asano Y. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity. 6:1997;673-679.
20. Lohoff M., Ferrick D., Mittrucker H.W., Duncan G.S., Bischof S., Rollinghoff M., Mak T.W. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity. 6:1997;681-689.
21. Hurgin V., Novick D., Rubinstein M. The promoter of IL-18 binding protein activation by an IFN-gamma-induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein beta . Proc. Natl. Acad. Sci. USA. 99:2002;16957-16962.
22. Fantuzzi G., Reed D., Qi M., Scully S., Dinarello C.A., Senaldi G. Role of interferon regulatory factor-1 in the regulation of IL-18 production and activity. Eur. J. Immunol. 31:2001;369-375.
23. S. Heinz, V. Haehnel, M. Karaghiosoff, L. Schwarzfischer, M. Muller, S.W. Kraus, M. Rehli, Species-specific regulation of toll-like receptor 3 genes in men and mice, J. Biol. Chem. Apr, 2003.
24. Tamura T., Ishihara M., Lamphier M.S., Tanaka N., Oishi I., Aizawa S., Mat-suyama T., Mak T.W., Taki S., Taniguchi T. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature. 376:1995;596-599.
25. Tendler D.S., Bao C., Wang T., Huang E.L., Ratovitski E.A., Pardoll D.A., Lowenstein C.J. Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumor apoptosis. Cancer Res. 61:2001;3682-3688.
26. Xiong H., Zhu C., Li H., Chen F., Mayer L., Ozato K., Unkeless J.C., Plevy S.E. Complex formation of the interferon (IFN) consensus sequence-binding protein with IRF-1 is essential for murine macrophage IFN-gamma-induced iNOS gene expression. J. Biol. Chem. 278:2003;2271-2277.
27. Pamment J., Ramsay E., Kelleher M., Dornan D., Ball K.L. Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway. Oncogene. 21:2002;7776-7785.
28. Bos T.J., Bohmann D., Tsuchie H., Tjian R., Vogt P.K. Genome, v-jun encodes a nuclear protein with enhancer binding properties of AP-1. Cell. 52:1988;705-712.
29. Angel P., Allegretto E.A., Okino S.T., Hattori K., Boyle W.J., Hunter T., Karin M. Oncogene jun encodes a sequence-specific transactivator similar to AP-1. Nature. 332:1988;166-171.
30. Ryder K., Lau L.F., Nathans D. A gene activated by growth factors is related to the oncogene v-jun. Proc. Natl. Acad. Sci. USA. 85:1988;1487-1491.
31. Ryder K., Lanahan A., Perez-Albuerne E., Nathans D. jun-D a third member of the jun gene family . Proc. Natl. Acad. Sci. USA. 86:1989;1500-1503.
32. Omitted.
33. Liebermann D., Hoffman-Liebermann B. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade. Oncogene. 4:1989;583-592.
34. Liebermann D.A., Gregory B., Hoffman B. AP-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis. Int. J. Oncol. 12:1998;685-700.
35. Lord K.A., Abdollahi A., Hoffman-Liebermann B., Liebermann D.A. Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation. Mol. Cell. Biol. 13:1993;841-851.
36. Jochum W., Passegue E., Wagner E.F. AP-1 in mouse development and tumorigenesis. Oncogene. 20:2001;2401-2412.
37. Grigoriadis A.E., Wang Z.Q., Wagner E.F. Trends. Genet. 11:1995;436-441.
38. Johnson R.S., Spiegelman B.M., Papaioannou V. Cell. 71:1992;577-586.
39. Wang Z.Q., Ovitt C., Grigoriadis A.E., Mohle-Steinlein U., Ruther U., Wagner E.F. Bone and haematopoietic defects in mice lacking c-fos. Nature. 360:1992;741-745.
40. Passegue E., Jochum W., Schorpp-Kistner M., Mohle-Steinlein U., Wagner E.F. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell. 104:2001;21-32.
41. Yang M.Y., Liu T.C., Chang J.G., Lin P.M., Lin S.F. JunB gene expression is inactivated by methylation in chronic myeloid leukemia. Blood. 101:2003;3205-3211.
42. Rangatia J., Vangala R.K., Treiber N., Zhang P., Radomska H., Tenen D.G., Hiddemann W., Behre G. Downregulation of c-Jun expression by transcription factor C/EBPalpha is critical for granulocytic lineage commitment. Mol. Cell. Biol. 22:2002;8681-8694.
43. Milbrandt J. A nerve growth factor-induced gene encodes a possible transcription regulatory factor. Science. 238:1987;797-799.
44. Sukhatme V.P., Cao X., Chang L.C., Tsai-Morris C.W., Stamenkovich D., Ferreira P.C., Cohen D.R., Edwards S.A., Shows T.B., Curran T., Le Beau M.M., Adamson E.D. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell. 53:1988;37-43.
45. Christy B., Nathans L.F., Nathans D. A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with "zinc finger" sequences. Proc. Natl. Acad. Sci. 85:1988;7857-7861.
46. Krishnaraju K., Nguyen H.Q., Liebermann D.A., Hoffman B. The zinc finger transcription factor Egr-1 potentiates macrophage differentiation of hematopoietic cells. Mol. Cell. Biol. 15:1995;5507-5549.
47. Krishnaraju K., Liebermann D.A., Hoffman B. Lineage specific regulation of hematopoiesis by Hox-B8 (Hox2.4) Inhibition of granulocyte differentiation and potentiation of monocytic differentiation . Blood. 90:1997;1840-1849.
48. Krishnaraju K., Hoffman B., Liebermann D.A. The zinc finger transcription factor Egr-1 activates macrophage differentiation in M1 myeloblastic leukemia cells. Blood. 92:1998;1957-1966.
49. Krishnaraju K., Hoffman B., Liebermann D.A. Early growth response gene 1 stimulates development of hematopoietic progenitor cells along the macrophage lineage at the expense of the granulocyte and erythroid lineages. Blood. 97:2001;1298-1305.
50. Lee S.L., Wang Y., Milbrandt J. Unimpaired macrophage differentiation and activation in mice lacking the zinc finger transcription factor NGFI-A (Egr1). Mol. Cell. Biol. 16:1996;4566.
51. Liu C., Rangnekar V.M., Adamson E., Mercola D. Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther. 1:1998;3-28.
52. Tourtellotte W.G., Nagarajan R., Bartke A., Milbrandt J. Functional compensation by Egr4 in Egr1-dependent luteinizing hormone regulation & Leydig cell steroidogenesis. Mol. Cell Biol. 20:2000;5261-5268.
53. Lord K.A., Abdollahi A., Thomas S.M., J.S. Brugge M.DeMarco, Hoffman-Liebermann B., Liebermann D. Leukemia inhibitory factor and interleukin-6 trigger the same immediate early response including tyrosine phosphorylation upon induction of myeloid leukemia differentiation. Mol. Cell Biol. 11:1991;4371-4379.
54. Kaisho T., Akira S. Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice. Trends Immunol. 22:2001;78-83.
55. Feinstein E., Kimchi A., Wallach D., Boldin M., Varfolomeev E. The death domain a module shared by proteins with diverse cellular functions . Trends Biochem. Sci. 20:1995;342-344.
56. Hardiman G., Rock F.L., Balasubramanian S., Kastelein R.A., Bazan J.F. Molecular characterization and modular analysis of human MyD88. Oncogene. 13:1996;2467-2475.
57. Hofmann K., Tschopp J. The death domain motif found in Fas (Apo-1) and TNF receptor is present in proteins involved in apoptosis and axonal guidance. FEBS Lett. 371:1995;321-323.
58. Hultmark D. Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family. Biochem. Biophys. Res. Commun. 199:1994;144-146.
59. Mitcham J.L., Parnet P., Bonnert T.P., Garka K.E., Gerhart M.J., Slack J.L., Gayle M.A., Dower S.K., Sims J.E. T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family. J. Biol. Chem. 271:1996;5777-5783.
60. M. Yamagata, J.P. Merlie, J.R. Sanes, Interspecific comparisons reveal conserved features of the Drosophila Toll protein, Gene 139 (1994) 223-228.
61. Itoh N., Nagata S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 268:1993;10932-10937.
62. Tartaglia L.A., Ayres T.M., Wong G.H., Goeddel D.V. A novel domain within the 55 kd TNF receptor signals cell death. Cell. 74:1993;845-853.
63. Omitted.
64. Hashimoto C., Hudson K.L., Anderson V. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell. 52:1988;269-279.
65. Medzhitov R., Preston-Hurlburt P., Kopp E., Stadlen A., Chen C., Ghosh S., Janeway C.A. Jr. MyD88 is an adaptor protein in the Toll/IL-1 receptor family signaling pathways. Mol. Cell. 2:1998;253-258.
66. Parnet P., Garka K.E., Bonnert T.P., Dower S., Sims J.E. IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. J. Biol. Chem. 271:1996;3967-3970.
67. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood. 87:1996;2095-2147.
68. Barnes P.J., Karin M. Nuclear factor-kappaB a pivotal transcription factor in chronic inflammatory diseases . N. Engl. J. Med. 336:1997;1066-1071.
69. Omitted.
70. Baeuerle P.A., Baltimore D. NF-kappa B ten years after . Cell. 87:1996;13-20.
71. Baldwin A.S. Jr. The NF-kappa B and I kappa B proteins new discoveries and insights . Annul. Rev. Immunol. 14:1996;649-683.
72. Ghosh S., May M.J., Kopp E. NF-kappa B and Rel proteins evolutionarily conserved mediators of immune responses . Annu. Rev. Immunol. 16:1998;225-260.
73. Karin M. The NF-kappa B activation pathway its regulation and role in inflammation and cell survival . Cancer J. Sci. Am. (Suppl 1):1998;S92-S99.
74. Greenfeder S.A., Nunes P., Kwee L., Labow M., Chizzonite R.A., Ju G. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 270:1995;13757-13765.
75. Huang J., Gao X., Li S., Cao Z. Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc. Natl. Acad. Sci. USA. 94:1997;12829-12832.
76. Korherr C., Hofmeister R., Wesche H., Falk W. A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur. J. Immunol. 27:1997;262-267.
77. Wesche H., Korherr C., Kracht M., Falk W., Resch K., Martin M.U. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J. Biol. Chem. 272:1997;7727-7731.
78. Cao Z., Henzel W.J., Gao X. IRAK a kinase associated with the interleukin-1 receptor . Science. 271:1996;1128-1131.
79. Cao Z., Xiong J., Takeuchi M., Kurama T., Goeddel D.V. TRAF6 is a signal transducer for interleukin-1. Nature. 383:1996;443-446.
80. Aizawa S., Nakano H., Ishida T., Horie R., Nagai M., Ito K., Yagita H., Okumura K., Inoue J., Watanabe T. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation. J. Biol. Chem. 272:1997;2042-2045.
81. Duckett C.S., Gedrich R.W., Gilfillan M.C., Thompson C.B. Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2. Mol. Cell. Biol. 17:1997;1535-1542.
82. Hsu H., Shu H.B., Pan M.G., Goeddel D.V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:1996;299-308.
83. Ishida T.K., Tojo T., Aoki T., Kobayashi N., Ohishi T., Watanabe T., Yamamoto T., Inoue J. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc. Natl. Acad. Sci. USA. 93:1996;9437-9442.
84. Nakano H., Oshima H., Chung W., Williams-Abbott L., Ware C.F., Yagita H., Okumirra K. TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor. J. Biol. Chem. 271:1996;14661-14664.
85. Rothe M., Sarma V., Dixit V.M., Goeddel D.V. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science. 269:1995;424-1427.
86. Di Donato J.A., Hayakawa M., Rothwarf D.M., Zandi E., Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature. 388:1997;548-554.
87. Malinin N.L., Boldin M.P., Kovalenko A.V., Wallach D. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature. 385:1997;540-544.
88. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., Young D.B., Barbosa M., Mann M., Manning A., Rao A. IKK-1 and IKK-2 cytokine-activated 1kappaB kinases essential for NF-kappaB activation . Science. 278:1997;860-866.
89. Regnier C.H., Song H., Gao X., Goeddel D.V., Cao Z., Rothe M. Identification and characterization of an IkappaB kinase. Cell. 90:1997;373-383.
90. Song H.Y., Regnier C.H., Kirschning C.J., Goeddel D.V., Rothe M. Tumor necrosis factor (TNF)-mediated kinase cascades bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2 . Proc. Natl. Acad. Sci. USA. 94:1997;9792-9796.
91. Woronicz J.D., Gao X., Cao Z., Rothe M., Goeddel D.V. 1kappaB kinase-beta NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK . Science. 278:1997;66-870.
92. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., Karin M. The 1kappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell. 91:1997;243-252.
93. Yanagisawa K., Takagi T., Tsukamoto T., Tetsuka T., Tominaga S. Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett. 318:1993;83-87.
94. Lovenberg T.W., Crowe P.D., Liu C., Chalmers D.T., Liu X.J., Liaw C., Clevenger W., Oltersdorf T., De Souza E.B., Maki R.A. Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL 1R-rp2). J. Neuroimmunol. 70:1996;113-122.
95. Parnet P., Garka K.E., Bonnert T.P., Dower S., Sims J.E. IL-1Rrp is a novel receptor-like molecule similar to the type 1 interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. J. Biol. Chem. 271:1996;3967-3970.
96. Medzhitov R., Preston-Hurlburt P., Janeway C.A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:1997;394-397.
97. Parker J.E., Coleman M.J., Szabo V., Frost L.N., Schmidt R., van der Biezen E.A., Moores T., Dean C., Daniels M.J., Jones J.D. The Arabidopsis downy mildew resistance gene RPP5 shares similarity to the toll and interleukin-1 receptors with N and L6. Plant Cell. 9:1997;879-894.
98. Eldon E., Kooyer S., D'Evelyn D., Duman M., Lawinger P., Botas J., Bellen H. The Drosophila 18 wheeler is required for morphogenesis and has striking similarities to Toll. Development. 120:1994;885-899.
99. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., Hoflmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cac tus controls the potent antifungal response in Drosophila adults. Cell. 86:1996;973-983.
100. Wasserman S.A. A conserved signal transduction pathway regulating the activity of the rel-like proteins dorsal and NF-kappa B. Mol. Biol. Cell. 4:1993;767-771.
101. Belvin M.P., Anderson K.V. A conserved signaling pathway the Drosophila toll-dorsal pathway . Annul Rev. Cell. Dev. Biol. 12:1996;393-416.
102. Norris J.L., Manley J.L. Functional interactions between the pelle kinase, Toll receptor, and tube suggest a mechanism for activation of dorsal. Genes Dev. 10:1996;862-872.
103. Letsou A., Alexander S., Wasserman S.A. Domain mapping of tube, a protein essential for dorsoventral patterning of the Drosophila embryo. EMBO J. 12:1993;3449-3458.
104. Shelton C.A., Wasserman S.A. Pelle encodes a protein kinase required to establish dorsoventral polarity in the Drosophila embryo. Cell. 7:1993;515-525.
105. Galindo R.L., Edwards D.N., Gillespie S.K., Wasserman S.A. Interaction of the pelle kinase with the membrane-associated protein tube is required for transduction of the dorsoventral signal in Drosophila embryos. Development. 121:1995;2209-2218.
106. Grosshans J., Bergmann A., Haffter P., Nusslein-Volhard C. Activation of the kinase Pelle by Tube in the dorsoventral signal transduction pathway of Drosophila embryo. Nature. 372:1994;563-566.
107. Burns K., Martinon F., Esslinger C., Pahl H., Schneider P., Bodmer J.L., Di Marco F., French L., Tschopp J. MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273:1998;12203-12209.
108. Wesche H., Henzel W.J., Shillinglaw W., Li S., Cao Z.I. MyD88 an adapter that recruits IRAK to the IL-1 receptor complex . Immunity. 7:1997;837-847.
109. Muzio M., Ni J., Feng P., Dixit V.M. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science. 278:1997;1612-1651.
110. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature. 406:2001;782-787.
111. Medzhitov R., Preston-Hurlburt P., Kopp E., Stadlen A., Chen C., Ghosh S., Janeway C.A. Jr. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell. 2:1998;253-258.
112. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 21:2003;335-376.
113. Martin M.U., Wesche H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim. Biophys. Acta. 1592:2002;265-280.
114. Janssens S., Beyaert R.A. Universal role for MyD88 in TLR/IL-1R-mediated signaling. Trends Biochem. Sci. 27:2002;474-482.
115. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:1999;115-122.
116. Xu Y., Tao X., Shen B., Horng T., Medzhitov R., Manley J.L., Tong L. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature. 40:2000;111-115.
117. Medvedev A.E., Lentschat A., Wahl L.M., Golenbock D.T., Vogel S.N. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J. Immunol. 169:2002;5209-5216.
118. Muraille E., De Trez C., Brait M., De Baetselier P., Leo O., Carlier Y. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response. J. Immunol. 170:2003;4237-4241.
119. Scanga C.A., Aliberti J., Jankovic D., Tilloy F., Bennouna S., Denkers E.Y., Medzhitov R., Sher A. Cutting edge MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells . J. Immunol. 168:2002;5997-6001.
120. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., Nakanishi K., Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 9:1998;143-150.
121. O'Neill L.A. Toll-like receptor signal transduction and the tailoring of innate immunity a role for Mal? Trends Immunol. 23:2002;296-300.
122. Horng T., Barton G.M., Flavell R.A., Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature. 420:2002;329-333.
123. Yamamoto M., Sato S., Hemmi H., Sanjo H., Uematsu S., Kaisho T., Hoshino K., Takeuchi O., Kobayashi M., Fujita T., Takeda K., Akira S. Essential role for T1RAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature. 420:2002;324-329.
124. Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K., Akira S. Cutting edge a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling . J. Immunol. 169:2002;6668-6672.
125. Burns K., Janssens S., Brissoni B., Olivos N., Beyaert R., Tschopp J. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197:2003;263-268.
126. Kobayashi K., Hernandez L.D., Galan J.E., Janeway C.A. Jr, Medzhitov R., Flavell R.A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell. 110:2002;191-202.
127. Hsu H., Xiong J., Goeddel D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B. Cell. 81:1995;495-504.
128. Hsu H., Huang J., Shu H.B., Baichwal V., Goeddel D.V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity. 4:1996;387-396.
129. Boldin M.P., Goncharov T.M., Goltsev Y.V., Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 85:1996;803-815.
130. Grimm S., Stanger B.Z., Leder P. RIP and FADD two "death domain"-containing proteins can induce apoptosis by convergent, but dissociable, pathways . Proc. Natl. Acad. Sci. USA. 93:1996;10923-10927.
131. Muzio M., Chinnaiyan A.M., Kischkel F.C., O'Rourke K., Shevchenko A., Ni J., Scaffidi C., Bretz J.D., Zhang M., Gentz R., Mann M., Krammer P.H., Peter M.E., Dixit V.M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death - inducing signaling complex. Cell. 85:1996;817-827.
132. Jaunin F., Burns K., Tschopp J., Martin T.E., Fakan S. Ultrastructural distribution of the death-domain-containing MyD88 protein in HeLa cells. Exp. Cell Res. 243:1998;67-75.
133. Dupraz P., Cottet S., Hamburger F., Dolci W., Felley-Bosco E., Thorens B. Dominant negative MyD88 proteins inhibit interleukin-1beta/interferon-gamma-mediated induction of nuclear factor kappa B-dependent nitrite production and apoptosis in beta cells. J. Biol. Chem. 275:2000;37672-37678.
134. Schmidt A., Caron E., Hall A. Lipopolysaccharide-induced activation of beta2-integrin function in macrophages requires Irak kinase activity, p38 mitogen-activated protein kinase, and the Rap1 GTPase. Mol. Cell Biol. 21:2001;438-448.
135. Wang J., Kobayashi M., Han M., Choi S., Takano M., Hashino S., Tanaka J., Kondoh T., Kawamura K., Hosokawa M. MyD88 is involved in the signalling pathway for Taxol-induced apoptosis and TNF-alpha expression in human myelomonocytic cells. Br. J. Haematol. 118:2002;638-645.
136. Fornace A.J., Jackman J., Hollander M.C., Hoffman-Liebermann B., Liebermann D.A. Genotoxic-stress-response genes and growth-arrest genes gadd, MyD, and other genes induced by treatments eliciting growth arrest . Ann. NY Acad. Sci. 663:1992;139-154.
137. Fornace A.J. Jr. Mammalian genes induced by radiation; activation of genes associated with growth control. Annu. Rev. Genet. 26:1992;507-526.
138. Zhan Q., Lord K.A., Alamo I. Jr, Hollander M.C., Carrier F., Ron D., Kohn K.W., Hoffman B., Liebermann D.A., Fornace A.J. Jr. The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol. Cell. Biol. 14:1994;2361-2371.
139. Su Z.Z., Shi Y., Fisher P.B. Subtraction hybridization identifies a transformation progression-associated gene PEG-3 with sequence homology to a growth arrest and DNA damage-inducible gene. Proc. Natl. Acad. Sci. USA. 94:1997;9125-9130.
140. McGeoch D.J., Barnett B.C. Neurovirulence factor. Nature. 353:1991;609.
141. Chou J., Roizman B. Herpes simplex virus 1 gamma(1)34.5 gene function, which blocks the host response to infection, maps in the homologous domain of the genes expressed during growth arrest and DNA damage. Proc. Natl. Acad. Sci. USA. 91:1994;5247-5251.
142. He B., Chou J., Liebermann D.A., Hoffman B., Roizman B., Marjorie B. The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the gamma(1)34.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells. J. Virol. 70:1996;84-90.
143. He B., Gross M., Roizman B. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA. 94:1997;843-848.
144. Sussman M.D., Lu Z., Kutish G., Afonso C.L., Roberts P., Rock D.L. Identification of an African swine fever virus gene with similarity to a myeloid differentiation primary response gene and a neurovirulence-associated gene of herpes simplex virus. J. Virol. 66:1992;5586-5591.
145. Vydelingum S., Baylis S.A., Bristow C., Smith G.L., Dixon L.K. Duplicated genes within the variable right end of the genome of a pathogenic isolate of African swine fever virus. J. Gen. Virol. 74:1993;2125-2130.
146. Dixon L.K., Twigg S.R., Baylis Delingum S.A., Bristow C., Hammond J.M., Smith G.L. Nucleotide sequence of a 55 kbp region from the right end of the genome of a pathogenic African swine fever virus isolate (Malawi LIL20/1). J. Gen. Virol. 75:1994;1655-1684.
147. Zsak L., Lu Z., Kutish G.F., Neilan J.G., Rock D.L. An African swine fever virus virulence-associated gene NL-S with similarity to the herpes simplex virus ICP34.5 gene. J. Virol. 70:1996;8865-8871.
148. Hollander M.C., Sheikh M.S., Yu K., Zhan Q., Iglesias M., Woodworth C., Fornace A.J. Jr. Activation of Gadd34 by diverse apoptotic signals and suppression of its growth inhibitory effects by apoptotic inhibitors. Int. J. Cancer. 96:2001;22-31.
149. Amundson S.A., Myers T.G., Scudiero D., Kitada S., Reed J.C., Fornace A.J. Jr. An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res. 60:2000;6101-6110.
150. Novoa I., Zeng H., Harding H.P., Ron D. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J. Cell Biol. 153:2001;1011-1022.
151. Novoa I., Zhang Y., Zeng H., Jungreis R., Harding H.P., Ron D. Stress-induced gene expression requires programmed recovery from translational repression. EMBO J. 22:2003;1180-1187.
152. Brush M.H., Weiser D.C., Shenolikar S. Growth arrest and DNA damage-inducible protein GADD34 targets protein phosphatase 1 alpha to the endoplasmic reticulum and promotes dephosphorylation of the alpha subunit of eukaryotic translation initiation factor 2. Mol. Cell Biol. 23:2003;1292-1303.
153. Adler H.T., Chinery R., Wu D.Y., Kussick S.J., Payne J.M., Fornace A.J. Jr., Tkachuk D.C. Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins. Mol. Cell Biol. 19:1999;7050-7060.
154. Brown S.M., MacLean A.R., McKie E.A., Harland J.J. The herpes simplex virus virulence factor ICP34.5 and the cellular protein MyD116 complex with proliferating cell nuclear antigen through the 63-amino-acid domain conserved in ICP34.5, MyD116, and GADD34. Virology. 71:1997;9442-9449.
155. Hasegawa T., Yagi A., Isobe K. Interaction between GADD34 and kinesin superfamily, KIF3A. Biochem. Biophys. Res. Commun. 267:2000;593-596.
156. Hasegawa T., Xiao H., Hamajima F., Isobe K. Interaction between DNA-damage protein GADD34 and a new member of the Hsp40 family of heat shock proteins that is induced by a DNA-damaging reagent. Biochem. J. 352:(Pt 3):2000;795-800.
157. Hasegawa T., Isobe K. Evidence for the interaction between Translin and GADD34 in mammalian cells. Biochim. Biophys. Acta. 1428:1999;161-168.
158. Hasegawa T., Xiao H., Isobe K. Cloning of a GADD34-like gene that interacts with the zinc-finger transcription factor which binds to the p21 (WAF) promoter. Biochem. Biophys. Res. Commun. 256:1999;249-254.
159. Hung W.J., Roberson R.S., Taft J., Wu D.Y. Human BAG-1 proteins bind to the cellular stress response protein GADD34 and interfere with GADD34 functions. Mol Cell Biol. 23:2003;3477-3486.
160. Zhang W., Bae I., Krishnaraju K., Azam N., Fan W., Smith K., Hoffman B., Liebermann D.A. CR6, A third member in the MyD118 & Gadd 45 gene family which functions in negative growth control. Oncogene. 18:1999;4899-4907.
161. Takekawa M., Saito H. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4/MAPKKK. Cell. 95:1998;521-530.
162. Balliet A.G., Hatton K.S., Hoffman B., Liebermann D.A. Comparative analysis of the genetic structure and chromosomal location of the murine MyD118 (Gadd45beta) gene. DNA Cell Biol. 20:2001;2347-2392.
163. A.G. Balliet, M.C. Hollander, A.J. Fornace Jr., B. Hoffman, D.A. Liebermann, Comparative 2001 analysis of the genetic structure and chromosomal location of the murine Gadd45g(CR6) gene, DNA Cell Biol. 2003 in press.
164. Papathanasiou M.A., Kerr N.C., Robbins J.H., McBride O.W., Alamo I. Jr., Barrett S.F., Hickson I.D., Fornace A.J. Jr. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol. Cell Biol. 10:1989;4196-4203.
165. Fornace A.J. Jr, Nebert D.W., Hollander M.C., Luethy J.D., Papathanasiou M., Fargnoli J., Holbrook N.J. Induction by ionizing radiation of the gadd45 gene in cultured human cells lack of mediation by protein kinase C . Mol. Cell Biol. 11:1991;1009-1016.
166. Vairapandi M., Balliet A.G., Hoffman B., Liebermann D.A. The differentiation primary response gene MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21 WAF1/CIP1. Oncogene. 12:1996;2579-2594.
167. Liebermann D.A., Hoffman B. MyD genes in negative growth control. Oncogene Rev. 17:1998;3319-3330.
168. Selvakumaran M., Lin H.K., Tjin Tham Sjin R., Reed J., Liebermann D., Hoffman B. The novel primary response gene MyD118 and the proto-oncogenes myb, myc and bcl-2 modulate transforming growth factor b1-induced apoptosis of myeloid leukemia cells. Mol. Cell. Biol. 14:1994;2352-2360.
169. Selvakumaran M., Lin H.K., Miyashita T., Wang H.G., Krajewski S., Reed J.C., Hoffman B., Liebermann D. Immediate early up-regulation of bax expression by p53 but not TGFb1 a paradigm for distinct apoptotic pathways . Oncogene. 9:1994;1791-1798.
170. Guillouf C., Grana X., Selvakumaran M., Hoffman B., Giordano A., Liebermann D.A. Dissection of the genetic programs of p53 G1 growth arrest and apoptosis blocking p53-induced apoptosis unmasks G1 arrest . Blood. 85:1995;2691-2698.
171. Kastan M.B., Zhan Q., El-Deiry W.S., Carrier F., Jacks T., Walsh W.V., Plunkett B.S., Vogelstein B., Fornace A.J. Jr. A mammalian cell cycle checkpoint utilizing p53 and gadd45 is defective in Ataxia-telangiectasia. Cell. 71:1992;587-597.
172. W. Zhang, The MyD118/Gadd4/CR6 gene gamily in negative growth control, Thesis. Temple University, July 2000.
173. Wang X., Gorospe M., Holbrook N.J. Gadd45 is not required for activation of c-Jun N-terminal kinase or p38 during acute stress. J. Biol. Chem. 274:1999;29599-29602.
174. Shaulian E., Karin M. Stress-induced JNK activation is independent of Gadd45 induction. J. Biol. Chem. 274:1999;29595-29598.
175. Hollander M.C., Sheikh M.S., Bulavin D.V., Lundgren K., Augeri-Henmueller L., Shehee R., Molinaro T.A., Kim K.E., Tolosa E., Ashwell J.D., Rosenberg M.P., Zhan Q., Fernandez-Salguero P.M., Morgan W.F., Deng C.X., Fornace A.J. Jr. Genomic instability in Gadd45a-deficient mice. Nat. Genet. 23:1999;176-184.
176. Vairapandi M., Balliet A.G., Hoffman B., Liebermann D.A. GADD45b and GADD45g are cdc2/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress. J. Cell Physiol. 192:2002;327-338.
177. Jin S., Tong T., Fan W., Fan F., Antinore M.J., Zhu X., Mazzacurati L., Li X., Petrik K.L., Rajasekaran B., Wu M., Zhan Q. GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity. Oncogene. 21:2002;8696-8704.
178. Smith M.L., Chen I.T., Zhan Q., Bae I., Chen C.Y., Gilmer T.M., Kastan M.B., O'Connor P.M., Fornace A.J. Jr. Protein interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science. 266:1994;1376-1380.
179. Smith M.L., Ford J.M., Hollander M.C., Bortnick R.A., Amundson S.A., Seo Y.R., Deng C.X., Hanawalt P.C., Fornace A.J. Jr. p53-mediated DNA repair responses to UV radiation studies of mouse cells lacking p53, p21, and/or gadd45 genes . Mol. Cell Biol. 20:2000;3705-3774.
180. Hartman A.R., Ford J.M. BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair. Nat. Genet. 32:2002;180-184.
181. Zhang W., Hoffman B., Liebermann D.A. Ectopic expression of MyD118/Gadd45/CR6 (Gadd45beta/alpha/gamma) sensitizes neoplastic cells to genotoxic stress-induced apoptosis. Int. J. Oncol. 18:2001;749-757.
182. Vairapandi M., Azam N., Balliet A.G., Hoffman B., Liebermann D.A. Characterization of MyD118, Gadd45, and PCNA interacting domains PCNA impedes MyD/Gadd mediated negative growth control . J. Biol. Chem. 275:2000;16810-16819.
183. Harkin D.P., Bean J.M., Miklos D., Song Y.H., Truong V.B., Englert C., Christians F.C., Ellisen L.W., Maheswaran S., Oliner J.D., Haber D.A. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell. 97:1999;575-586.
184. Azam N., Vairapandi M., Zhang W., Hoffman B., Liebermann D.A. Interaction of CR6 (GADD45 {gamma}) with proliferating cell nuclear antigen (PCNA) impedes negative growth control. J. Biol. Chem. 276:2000;2766-2774.
185. Smith M.L., Kontny H.U., Zhan Q., Sreenath A., O'Connor P.M., Fornace A.J. Jr. Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to u.v.-irradiation or cisplatin. Oncogene. 13:1996;2255-2263.
186. Yang J., Zhu H., Murphy T.L., Ouyang W., Murphy K.M. IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production. Nat. Immunol. 2:2001;157-164.
187. Lu B., Yu H., Chow C., Li B., Zheng W., Davis R.J., Flavell R.A. GADD45gamma mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cells. Immunity, 14:2001;583-590.
188. Wang X.W., Zhan Q., Coursen J.D., Khan M.A., Kontny H.U., Yu L., Hollander M.C., O'Connor P.M., Fornace A.J. Jr., Harris C.C. GADD45 induction of a G2/M cell cycle checkpoint. Proc. Natl. Acad. Sci. USA. 96:1999;3706-3711.
189. Harkin D.P., Bean J.M., Miklos D., Song Y.H., Truong V.B., Englert C., Christians F.C., Ellisen L.W., Maheswaran S., Oliner J.D., Haber D.A. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell. 97:1999;575-586.
190. Li S., Ting N.S., Zheng L., Chen P.L., Ziv Y., Shiloh Y., Lee E.Y., Lee W.H. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature. 406:2000;210-215.
191. Kojima S., Mayumi-Matsuda K., Suzuki H., Sakata T. Molecular cloning of rat GADD45gamma, gene induction and its role during neuronal cell death. FEBS Lett. 446:1999;313-317.
192. Kovalsky O., Lung F.D., Roller P.P., Fornace A.J. Jr. Oligomerization of human Gadd45a protein. J. Biol. Chem. 276:2001;39330-39339.
193. Sancar A. Mechanisms of DNA excision repair. Science. 266:1994;1954-1956.
194. Jonsson Z.O., Hubsche U. Proliferating cell nuclear antigen more than a clamp for DNA polymerases . BioEssays. 19:1997;967-975.
195. Kelman Z., Hurwitz J. Protein-PCNA interactions a DNA-scanning mechanism? Trends Biochem. Sci. 23:1998;236-238.
196. Cheung K.J. Jr, Mitchell D., Lin P., Li G. The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA. Cancer Res. 61:2001;4974-4977.
197. Carrier F., Georgel P.T., Pourquier P., Blake M., Kontny H.U., Antinore M.J., Gariboldi M., Myers T.G., Weinstein J.N., Pommier Y., Fornace A.J. Jr. Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin. Mol. Cell Biol. 19:1999;1673-1685.
198. Zhan Q., Antinore M.J., Wang X.W., Carrier F., Smith M.L., Harris C.C., Fornace A.J. Jr. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene. 18:1999;2892-2900.
199. Jin S., Antinore M.J., Lung F.D., Dong X., Zhao H., Fan F., Colchagie A.B., Blanck P., Roller P.P., Fornace A.J. Jr, Zhan Q. The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression. J. Biol. Chem. 275:2000;16602-16608.
200. Yang Q., Manicone A., Coursen J.D., Linke S.P., Nagashima M., Forgues M., Wang X.W. Identification of a functional domain in a Gadd45-mediated G2/M checkpoint. J. Biol. Chem. 275:2000;36892-36898.
201. O'Connor P.M. Mammalian G1 and G2 phase checkpoints. Cancer Surv. 29:1997;151-182.
202. Elledge S.J. Cell cycle checkpoints preventing an identity crisis . Science. 274:1996;1664-1672.
203. Zhang H., Xiong Y., Beach D. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell. 4:1993;897-906.
204. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704.
205. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1. Cell. 75:1993;805-816.
206. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
207. Deng C., Zhang P., Harper J.W., Elledge S.J., Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 82:1995;675-684.
208. Chan T.A., Hwang P.M., Hermeking H., Kinzler K.W., Vogelstein B. Cooperative effects of genes controlling the G(2)/M checkpoint. Genes Dev. 14:2000;1584-1588.
209. Yan S.F., Fujita T., Lu J., Okada K., Shan Zou Y., Mackman N., Pinsky D.J., Stern D.M. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat. Med. 6:2000;1355-1361.
210. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
211. Sawyers C.L., Denny C.T., Witte O.N. Leukemia and the disruption of normal hematopoiesis. Cell. 64:1991;337-350.
212. Stanbridge E.J., Nowell P.C. Origins of human cancer revisited. Cell. 63:1990;867-874.